Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort.
暂无分享，去创建一个
J. Baselga | M. Climent | W. Eiermann | A. Lluch | V. Semiglazov | L. Gianni | M. Lichinitser | S. Tjulandin | P. Valagussa | M. Zambetti | E. Ciruelos | F. Vázquez | J. Steinseifer | D. Magazzù | B. Ojeda | A. Moliterni | D. Heinzmann | M. Mansutti | A. Bozhok | M. Byakhov | D. Magazzù